[Kaposi sarcoma associated with infliximab treatment].
Martínez-Martínez
M L
ML
Pérez-García
L J
LJ
Escario-Travesedo
E
E
Ribera-Vaquerizo
P A
PA
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D012514:Sarcoma, Kaposi / Q000139:chemically induced*; D012878:Skin Neoplasms / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab